StonvexLoading…
StonvexStonvexStonvexCore line items from SPB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.81B | $2.96B | $2.92B | $3.13B |
Operating Income | $124.90M | $170.60M | $-205.60M | $23.20M |
Net Income | $99.90M | $124.80M | $1.80B | $71.60M |
EPS (Diluted) | $3.86 | $4.10 | $45.65 | $1.75 |
Total Assets | $3.38B | $3.84B | $5.26B | $5.78B |
Total Liabilities | $1.47B | $1.70B | $2.74B | $4.51B |
Cash & Equivalents | $123.60M | $368.90M | $753.90M | $243.70M |
Free Cash Flow OCF − CapEx | $165.30M | $118.60M | $-468.70M | $-117.80M |
Shares Outstanding | 25.90M | 30.50M | 39.50M | 40.90M |